World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
62
Citations
16987
World Ranking
10639
National Ranking
4623

Massimo Fantini publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Massimo Fantini sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 211 publications — 54th percentile

54% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Massimo Fantini D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Massimo Fantini sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 62 D-Index — 46th percentile

46% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Massimo Fantini is affiliated with Precision Biologics in the United States and has contributed extensively to research in medicine, with a particular focus on biochemistry, genetics, and molecular biology. Their work spans multiple subfields, including radiology, nuclear medicine and imaging, molecular biology, oncology, immunology, and organic chemistry.

The scientist's research topics emphasize monoclonal and polyclonal antibodies, glycosylation and glycoproteins, immunotherapy and immune responses, radiopharmaceutical chemistry and applications, cancer treatment and pharmacology, cancer immunotherapy and biomarkers, as well as cancer research and treatments.

Among the recent papers involving Massimo Fantini are:

  • First-in-human phase 1 clinical trial of anti-core 1 O-glycans targeting monoclonal antibody NEO-201 in treatment-refractory solid tumors, 2023, Journal of Experimental & Clinical Cancer Research
  • The Monoclonal Antibody NEO-201 Enhances Natural Killer Cell Cytotoxicity Against Tumor Cells Through Blockade of the Inhibitory CEACAM5/CEACAM1 Immune Checkpoint Pathway, 2020, Cancer Biotherapy and Radiopharmaceuticals
  • Development and Characterization of an Anti-Cancer Monoclonal Antibody for Treatment of Human Carcinomas, 2022, Cancers
  • Guidance for Fecal Microbiota Transplantation Trials in Ulcerative Colitis: The Second ROME Consensus Conference, 2025, Inflammatory Bowel Diseases
  • Phase II Study of Ensituximab, a Novel Chimeric Monoclonal Antibody, in Adults with Unresectable, Metastatic Colorectal Cancer, 2020, Clinical Cancer Research

Frequent co-authors collaborating with Massimo Fantini include Kwong Y. Tsang, Philip M. Arlen, Christina M. Annunziata, Sharon Mavroukakis, and Anjum Zaki. This indicates recurring collaborative relationships across various projects.

Massimo Fantini has published in several venues multiple times, notably:

  • Regular and Young Investigator Award Abstracts
  • Journal of Clinical Oncology
  • Cancer Research
  • Journal of Experimental & Clinical Cancer Research
  • Cancers

The scientist's work contributes broadly to understanding and developing treatments related to cancer, immunotherapy, and molecular targeted agents, with particular attention to monoclonal antibodies and their applications in oncology and related biomedical fields.

Best Publications

  • Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7.

    Massimo C. Fantini;Christoph Becker;Giovanni Monteleone;Francesco Pallone

  • TGF-β Suppresses Tumor Progression in Colon Cancer by Inhibition of IL-6 trans-Signaling

    Christoph Becker;Massimo C. Fantini;Christoph Schramm;Hans A. Lehr

  • Th17-type cytokines, IL-6 and TNF-α synergistically activate STAT3 and NF-kB to promote colorectal cancer cell growth.

    V De Simone;E Franzè;G Ronchetti;A Colantoni

  • Antibody-Dependent Cellular Cytotoxicity Activity of a Novel Anti-PD-L1 Antibody Avelumab (MSB0010718C) on Human Tumor Cells.

    Benjamin Boyerinas;Caroline Jochems;Massimo Fantini;Christopher R. Heery

  • TNF-α and IFN-γ regulate the expression of the NOD2 (CARD15) gene in human intestinal epithelial cells ☆ ☆☆ ★ ★★ ♢

    Philip Rosenstiel;Massimo Fantini;Massimo Fantini;Karen Bräutigam;Tanja Kühbacher

  • Mongersen, an Oral SMAD7 Antisense Oligonucleotide, and Crohn’s Disease

    Giovanni Monteleone;Markus F. Neurath;Sandro Ardizzone;Antonio Di Sabatino

  • High resolution colonoscopy in live mice.

    C Becker;M C Fantini;M F Neurath

  • IL-21 Counteracts the Regulatory T Cell-Mediated Suppression of Human CD4+ T Lymphocytes

    Ilaria Peluso;Massimo Claudio Fantini;Daniele Fina;Roberta Caruso

  • In vitro and in vivo antitumoral effects of combinations of polyphenols, or polyphenols and anticancer drugs: perspectives on cancer treatment

    Massimo Fantini;Monica Benvenuto;Laura Masuelli;Giovanni Vanni Frajese

  • Regulation of Gut Inflammation and Th17 Cell Response by Interleukin-21

    Daniele Fina;Massimiliano Sarra;Massimo C. Fantini;Angelamaria Rizzo

  • IL-6 signaling promotes tumor growth in colorectal cancer.

    C Becker;M C Fantini;S Wirtz;A Nikolaev

  • Regulation of homeostasis and inflammation in the intestine.

    Thomas T. MacDonald;Ivan Monteleone;Massimo Claudio Fantini;Giovanni Monteleone

  • Transforming growth factor beta induced FoxP3+ regulatory T cells suppress Th1 mediated experimental colitis

    Massimo C Fantini;Christoph Becker;Ingrid Tubbe;Alexei Nikolaev

  • Unique role of junctional adhesion molecule-a in maintaining mucosal homeostasis in inflammatory bowel disease.

    Stefania Vetrano;Maria Rescigno;Maria Rosaria Cera;Carmen Correale

  • In vivo imaging of colitis and colon cancer development in mice using high resolution chromoendoscopy

    C Becker;M C Fantini;S Wirtz;A Nikolaev

  • Cutting Edge: Trans-Signaling via the Soluble IL-6R Abrogates the Induction of FoxP3 in Naive CD4+CD25− T Cells

    Sabine Dominitzki;Massimo C. Fantini;Clemens Neufert;Alexei Nikolaev

  • Cutting Edge: IL-23 Cross-Regulates IL-12 Production in T Cell-Dependent Experimental Colitis

    Christoph Becker;Heike Dornhoff;Clemens Neufert;Massimo C. Fantini

  • IL-27 controls the development of inducible regulatory T cells and Th17 cells via differential effects on STAT1.

    Clemens Neufert;Christoph Becker;Stefan Wirtz;Massimo C. Fantini

  • Control of matrix metalloproteinase production in human intestinal fibroblasts by interleukin 21

    Giovanni Monteleone;Roberta Caruso;Daniele Fina;Ilaria Peluso

  • TGF-beta suppresses tumor progression in colon cancer by inhibition of IL–6 trans-signaling

    C Becker;MC Fantini;C Schramm;HA Lehr

Frequent Co-Authors

Giovanni Monteleone
Giovanni Monteleone University of Rome Tor Vergata
Francesco Pallone
Francesco Pallone University of Rome Tor Vergata
Markus F. Neurath
Markus F. Neurath University of Erlangen-Nuremberg
Thomas T. MacDonald
Thomas T. MacDonald University of Southampton
Kwong Y. Tsang
Kwong Y. Tsang National Institutes of Health
Christoph Becker
Christoph Becker University of Erlangen-Nuremberg
Andrea Modesti
Andrea Modesti University of Rome Tor Vergata
Philip M. Arlen
Philip M. Arlen National Institutes of Health
Jeffrey Schlom
Jeffrey Schlom National Institutes of Health
Peter R. Galle
Peter R. Galle Johannes Gutenberg University of Mainz

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a degree in Biology or Biochemistry in the USA offers many exciting career options. Students interested in nutrition and food science may consider the best dietetics masters programs to specialize in dietetics and help promote better health outcomes.

For those seeking entry-level healthcare roles, there are online medical assistant programs fafsa approved that provide affordable and flexible pathways, making it easier to start working in medical settings.

Medical assistants looking to advance further in their careers can benefit from a cma to lpn bridge program online. These programs create smooth transitions toward becoming a Licensed Practical Nurse, opening up more responsibilities and higher earning potential.

If you’re eager to study biology from anywhere or accelerate your career change, a biology degree online is an excellent choice. Online degrees offer flexibility and can be completed on a faster track compared to traditional on-campus programs.

Whether you’re starting out or seeking further specialization, these online pathways can help you build a rewarding career rooted in the life sciences.

Best Scientists Citing Massimo Fantini

Trending Scientists

Recently Published Articles